Zealand Pharma Announces Presentation of Preclinical Data on Amylin Analogue, ZP8396, and Clinical Data on Glucagon-GLP1 Dual-Agonist, BI 456906, at The Obesity Society Annual Meeting

https://www.globenewswire.com/news-release/2021/11/01/2324655/0/en/Zealand-Pharma-Announces-Presentation-of-Preclinical-Data-on-Amylin-Analogue-ZP8396-and-Clinical-Data-on-Glucagon-GLP1-Dual-Agonist-BI-456906-at-The-Obesity-Society-Annual-Meeting.html

press release